Meiqiu Yan

441 total citations
36 papers, 320 citations indexed

About

Meiqiu Yan is a scholar working on Molecular Biology, Pharmacology and Neurology. According to data from OpenAlex, Meiqiu Yan has authored 36 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pharmacology and 6 papers in Neurology. Recurrent topics in Meiqiu Yan's work include Biological and pharmacological studies of plants (8 papers), Phytochemistry and Biological Activities (4 papers) and Ginseng Biological Effects and Applications (3 papers). Meiqiu Yan is often cited by papers focused on Biological and pharmacological studies of plants (8 papers), Phytochemistry and Biological Activities (4 papers) and Ginseng Biological Effects and Applications (3 papers). Meiqiu Yan collaborates with scholars based in China, Singapore and Macao. Meiqiu Yan's co-authors include Suhong Chen, Guiyuan Lv, Jie Su, Jingjing Yu, Shanshan Lei, Yajun Wang, Yuzhi Wang, Ziwen He, Lianghui Zhan and Tingting Lu and has published in prestigious journals such as The FASEB Journal, Journal of Ethnopharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Meiqiu Yan

34 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiqiu Yan China 9 157 90 80 45 35 36 320
Yayun Wu China 12 150 1.0× 63 0.7× 64 0.8× 59 1.3× 31 0.9× 33 369
Wenya Zheng China 11 143 0.9× 52 0.6× 94 1.2× 72 1.6× 27 0.8× 29 411
Haihong Chen China 10 160 1.0× 110 1.2× 136 1.7× 32 0.7× 21 0.6× 19 494
Young‐Sik Kim South Korea 14 158 1.0× 59 0.7× 72 0.9× 40 0.9× 68 1.9× 54 494
Eun-Yong Choi South Korea 11 142 0.9× 46 0.5× 69 0.9× 20 0.4× 38 1.1× 15 335
Jinyang Shen China 12 145 0.9× 35 0.4× 52 0.7× 44 1.0× 35 1.0× 43 436
Fabian Priem Belgium 7 184 1.2× 160 1.8× 69 0.9× 56 1.2× 45 1.3× 7 436
Se Jin Park South Korea 9 106 0.7× 80 0.9× 58 0.7× 52 1.2× 38 1.1× 20 338
Yan‐Ying Lu Taiwan 13 132 0.8× 138 1.5× 57 0.7× 41 0.9× 52 1.5× 19 469
Joo Wan Kim South Korea 11 199 1.3× 31 0.3× 44 0.6× 40 0.9× 51 1.5× 31 366

Countries citing papers authored by Meiqiu Yan

Since Specialization
Citations

This map shows the geographic impact of Meiqiu Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiqiu Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiqiu Yan more than expected).

Fields of papers citing papers by Meiqiu Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiqiu Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiqiu Yan. The network helps show where Meiqiu Yan may publish in the future.

Co-authorship network of co-authors of Meiqiu Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Meiqiu Yan. A scholar is included among the top collaborators of Meiqiu Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiqiu Yan. Meiqiu Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yu, Qian Huang, Huiwen Zhang, et al.. (2025). The n-butanol extract of Polygonatum sibiricum improves spleen aging via p53 pathway. Phytomedicine. 144. 156888–156888. 1 indexed citations
2.
Su, Jie, Xiaorui Su, Yanmei Dong, et al.. (2025). Study on the unique effects of Wubi Shanyao Pills in improving postmenopausal osteoporosis via the “gut-bone” axis. Phytomedicine. 148. 157447–157447.
4.
Zhang, Huiwen, Ziwen He, Yulan Chen, et al.. (2024). Cordyceps polysaccharide improves polycystic ovary syndrome by inhibiting gut-derived LPS/TLR4 pathway to attenuates insulin resistance. International Journal of Biological Macromolecules. 280(Pt 3). 135844–135844. 8 indexed citations
5.
Yan, Meiqiu, Jingjing Yu, Xueling Hu, et al.. (2024). Gut microbiota dysbiosis and intestinal barrier impairment in diarrhea caused by cold drink and high-fat diet. Toxicology. 502. 153728–153728. 8 indexed citations
6.
7.
He, Ziwen, Huiwen Zhang, Yiqing Zhou, et al.. (2023). Atractylodes macrocephala Koidz polysaccharide improves glycolipid metabolism disorders through activation of aryl hydrocarbon receptor by gut flora-produced tryptophan metabolites. International Journal of Biological Macromolecules. 253(Pt 4). 126987–126987. 36 indexed citations
8.
Lou, Zhaohuan, Liping Han, Meiqiu Yan, et al.. (2023). Multi-Omics Identified THDCA as a Key Contributor to Hyperlipidemia and as a Potential Therapeutic Agent. Reviews in Cardiovascular Medicine. 24(9). 248–248. 2 indexed citations
10.
Su, Jie, Yajun Wang, Meiqiu Yan, et al.. (2022). The beneficial effects of Polygonatum sibiricum Red. superfine powder on metabolic hypertensive rats via gut-derived LPS/TLR4 pathway inhibition. Phytomedicine. 106. 154404–154404. 34 indexed citations
11.
Su, Jie, Jingjing Yu, Meiqiu Yan, et al.. (2021). Luteolin ameliorates lipopolysaccharide-induced microcirculatory disturbance through inhibiting leukocyte adhesion in rat mesenteric venules. BMC Complementary Medicine and Therapies. 21(1). 33–33. 5 indexed citations
12.
Wang, Yajun, Jie Su, Jingjing Yu, et al.. (2021). Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway. Frontiers in Pharmacology. 12. 755140–755140. 17 indexed citations
13.
Su, Jie, Ting Wang, Meiqiu Yan, et al.. (2021). [Effect of Dendrobii officinalis superfine powder on overeating greasy-induced metabolic hypertension in rats].. PubMed. 46(7). 1658–1666. 5 indexed citations
14.
Yang, Zhiyuan, et al.. (2021). [Protective effects of Dendrobium officinale superfine powder against LPS-induced intestinal mucosal injury in mice].. China Journal of Chinese Materia Medica. 46(7). 1667–1673. 2 indexed citations
15.
Yang, Ke, Tingting Lu, Lianghui Zhan, et al.. (2020). Physicochemical characterization of polysaccharide from the leaf of Dendrobium officinale and effect on LPS induced damage in GES-1 cell. International Journal of Biological Macromolecules. 149. 320–330. 55 indexed citations
17.
Lei, Shanshan, Bo Li, Xinglishang He, et al.. (2019). Dendrobii Officinalis, a traditional Chinese edible and officinal plant, accelerates liver recovery by regulating the gut-liver axis in NAFLD mice. Journal of Functional Foods. 61. 103458–103458. 42 indexed citations
19.
Yan, Meiqiu, et al.. (2016). FROM OFFLINE TO ONLINE: HOW HEALTH INSURANCE POLICIES DRIVE THE DEMAND FOR ONLINE HEALTHCARE SERVICE?. Institutional Knowledge (InK) - Institutional Knowledge at Singapore Management University (Singapore Management University). 387. 7 indexed citations
20.
Qiu, Liyan, Jianxiang Zhang, Meiqiu Yan, Yi Jin, & Kangjie Zhu. (2007). Reverse self-assemblies based on amphiphilic polyphosphazenes for encapsulation of water-soluble molecules. Nanotechnology. 18(47). 475602–475602. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026